SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings

The rapidly evolving coronavirus disease 2019 (COVID-19, caused by severe acute respiratory syndrome coronavirus 2- SARS-CoV-2), has greatly burdened the global healthcare system and led it into crisis in several countries. Lack of targeted therapeutics led to the idea of repurposing broad-spectrum...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Rajkumar Singh, Tomar, Dhanendra, Meena, Avtar Singh, Kandimalla, Ramesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400328/
https://www.ncbi.nlm.nih.gov/pubmed/32645974
http://dx.doi.org/10.3390/pathogens9070546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400328/
https://www.ncbi.nlm.nih.gov/pubmed/32645974
http://dx.doi.org/10.3390/pathogens9070546

Ejemplares similares